John Mastrototaro Sells 33,069 Shares of Movano (NASDAQ:MOVE) Stock

Movano Inc. (NASDAQ:MOVE) CEO John Mastrototaro sold 33,069 shares of the company’s stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total value of $687,835.20. Following the sale, the chief executive officer owned 56,114 shares in the company, valued at approximately $1,167,171.20. This represents a 37.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

John Mastrototaro also recently made the following trade(s):

• On Monday, January 5th, John Mastrototaro sold 2,514 shares of Movano stock. The shares were sold at an average price of $8.21, for a total transaction of $20,639.94.

Movano Trading Up 4.4%

NASDAQ MOVE opened at $19.07 on Friday. The firm has a market capitalization of $15.83 million, a P/E ratio of -1.76 and a beta of 0.79. The firm’s fifty day moving average price is $9.43 and its two-hundred day moving average price is $7.97. Movano Inc. has a 1 year low of $4.67 and a 1 year high of $55.00.

Movano (NASDAQ:MOVE) last announced its quarterly earnings data on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, beating analysts’ consensus estimates of ($7.00) by $2.27. The company had revenue of $0.08 million during the quarter, compared to the consensus estimate of $3.88 million. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on MOVE shares. Wall Street Zen lowered Movano from a “hold” rating to a “sell” rating in a report on Saturday, January 17th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC purchased a new stake in Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano at the end of the most recent quarter. Hedge funds and other institutional investors own 16.64% of the company’s stock.

Movano News Roundup

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Short interest dropped ~41% from Dec. 31 to Jan. 15, reducing the pool of bearish bets and lowering one source of selling pressure.
• Positive Sentiment: Technical: shares recently cleared the 200‑day moving average, a common momentum trigger that can attract retail and quant buying. Movano (NASDAQ:MOVE) Shares Pass Above 200-Day Moving Average
• Positive Sentiment: Institutional note — Citadel Advisors reported a new position in Movano (49,262 shares), which can signal professional interest and provide support.
• Neutral Sentiment: Market structure: multiple intraday LULD (limit up/limit down) pauses and trading halts were recorded — indicates volatility but not an underlying fundamental catalyst.
• Neutral Sentiment: Liquidity: today’s volume remains below the stock’s longer‑term average, so price moves may be amplified by lighter trading.
• Negative Sentiment: Insider selling — CEO John Mastrototaro sold 33,069 shares at about $20.80 (≈37% reduction in his stake). SEC filing: CEO Insider Sale Filing
• Negative Sentiment: Insider selling — CFO Jeremy Cogan sold 28,736 shares at about $20.78 (≈32% reduction in his stake). SEC filing: CFO Insider Sale Filing
• Negative Sentiment: Analyst/ratings pressure — WallStreetZen downgraded Movano to a “sell” and Weiss Ratings reiterated a sell view, keeping sentiment skewed among some brokerages. WallStreetZen downgrade
• Negative Sentiment: Fundamentals mixed — last reported quarter showed an EPS beat versus a very low consensus but revenue materially missed expectations and margins remain deeply negative, a longer‑term risk for valuation.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.